 SOUTH SAN FRANCISCO, Calif., Nov. 09, 2021 GLOBE NEWSWIRE -- Akero Therapeutics, Inc. Nasdaq: AKRO, a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference which will be available for on-demand viewing starting Thursday, November 18 at 3:00 a.m. EST. 